Amryt Pharma Share Discussion Threads

[waterloo01] 05/10/2017 10:09

timbo, great and look forward to some feedback. I guess questions around Lox and further trials/timing/funding plus questions around actions around the half time readout and implications either way.

[timbo003] 05/10/2017 09:57

Amryt are at Proactive investors tonight, you have to register to attend, but it's free. I've booked my place, so happy to ask any (sensible) questions anyone here may have.

[papillon] 04/10/2017 11:49

I'm busy tomorrow; I think I'll go to next weeks presentation instead. LOL. LOL.

Obviously there is no presentation next week (though one can never say never! LOL), but it does seem to me that AMYT presentations are NOT a rarity!

[aim_trader] 04/10/2017 10:33

Amryt Pharma will be presenting to investors at the upcoming Proactive One2One Healthcare Forum tomorrow from 6pm. For details and registration, please click here:

[waterloo01] 04/10/2017 10:15

Selected UK biotech doing well. Over the years have made good money on BTG and more recently with SUMM, IMM and Motif (all of which I remain fairly heavily invested).

I'm hoping that AMYT will be the next one to pop as it draws closer to results.

Patience though seems it short supply at times.

[greendragon777] 03/10/2017 20:08

Hear hear Bazworth.....here's to a cracking 2018! :-)

[bazworth] 03/10/2017 19:52

There's little point in worrying about the current share price The excitement should start during 2018 when we run up to the Phase 3 results. Having said that, who knows what could be announced with regard to deals similar to Lojuxta or perhaps bolt-on acquisitions. AMRYT is a fascinating gamble that I'm happy to hold and hope for a 'cracker' in 2018!!

[greendragon777] 03/10/2017 12:31

Nice one thanks Paps.....10th and 30th October if I read that right.

[papillon] 03/10/2017 12:14

"5. Details of the Placing
The Placing will raise, in aggregate, EUR15.0 million (GBP13.3 million) (before commissions and expenses) through the conditional placing of the Placing Shares at a price of 20 pence per share with institutional and other investors. The Placing Price represents a discount of approximately 20.4 per cent. to the Company's closing middle market price on 20 September 2017, being the last practicable date prior to the announcement of the Placing.

Due to the requirements of the VCT Legislation, the Company will complete the Placing in two tranches. The VCT Placing Shares will be issued and allotted to VCTs and will be admitted to AIM and ESM on First Admission. The Non-VCT Placing Shares will be issued and allotted to other investors who will not be seeking relief under the VCT Legislation and will be admitted to AIM and ESM on Second Admission.

The Placing Shares, when issued, will represent approximately 24.2 per cent. of the Company's Enlarged Share Capital immediately following Admission. The Placing Shares will rank in full for all dividends and other distributions with a record date on or after the date of First Admission in respect of the VCT Placing Shares and Second Admission in respect of the Non-VCT Placing Shares and will otherwise rank pari passu in all respects with the Ordinary Shares in issue from the date of the relevant Admission.

The Placing of the VCT Placing Shares (which is not being underwritten) is conditional, amongst other things, upon:

a) the Placing Agreement becoming or being declared unconditional in all respects in relation to the Placing of the VCT Placing Shares (save for First Admission) and not having been terminated in accordance with its terms in respect of the VCT Placing Shares prior to First Admission;

b) the passing of the Placing Resolutions set out in the Notice of General Meeting; and
c) by 3.30 p.m. on the business day immediately prior to the expected date of First Admission, the Company not having received written notification from HMRC that the VCT Placing Shares will not qualify pursuant to the VCT Legislation and the Company not having breached certain warranties in respect of its status under the VCT Legislation if repeated at such time;

d) Admission of the VCT Placing Shares becoming effective on or before 8.00 a.m. on 10 October 2017 or such later date as the Company and Shore Capital may agree, being no later than 8.00 a.m. on 31 October 2017.

If any of the conditions are not satisfied, the VCT Placing Shares will not be issued and all monies received will be returned.

The Placing of the Non-VCT Placing Shares (which is not being underwritten) is conditional, amongst other things, upon:

a) the Placing Agreement becoming or being declared unconditional in all respects in relation to the Placing of the Non-VCT Placing Shares (save for Second Admission) and not having been terminated in accordance with its terms in respect of the Non-VCT Placing Shares prior to Second Admission;

b) the passing of the Placing Resolutions set out in the Notice of General Meeting; and
c) Admission of the Non-VCT Placing Shares becoming effective on or before 8.00 a.m. on 11 October 2017 or such later date as the Company and Shore Capital may agree, being no later than 8.00 a.m. on 31 October 2017.

If any of the conditions are not satisfied, the Non-VCT Placing Shares will not be issued and all monies received will be returned.

5.1. The Placing Agreement
Pursuant to the terms of the Placing Agreement, the Bookrunners have conditionally agreed to use their respective reasonable endeavours, as agents for the Company, to procure subscribers for the Placing Shares at the Placing Price with certain institutional and other investors.

The Placing Agreement contains customary warranties from the Company in favour of the Bookrunners in relation to, inter alia, the accuracy of the information in this document and other matters relating to the Group and its business. In addition, the Company has agreed to indemnify the Bookrunners in relation to certain liabilities they may incur in respect of the Placing. The Bookrunners have the right to terminate the Placing Agreement in certain circumstances prior to First Admission in respect of the VCT Placing Shares and/or Second Admission in respect of the Non-VCT Placing Shares, in particular, in the event of a material breach of the warranties given in the Placing Agreement, the failure of the Company to comply in any material respect with its obligations under the Placing Agreement or the occurrence of certain force majeure events which in Shore Capital's opinion makes it impractical or inadvisable to continue with the Placing.

The Placing Agreement provides for payment by the Company to each of the Bookrunners of certain commissions and fees in connection with their appointment. The Company will bear certain other expenses of and incidental to the Placing.

5.2. Settlement and dealings
Applications will be made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM and to the Irish Stock Exchange for the Placing Shares to be admitted to ESM. It is expected that First Admission will become effective and dealings in the VCT Placing Shares will commence on AIM and ESM on 10 October 2017 and that Second Admission will become effective and dealings in the Non-VCT Placing Shares will commence on AIM and ESM on 11 October 2017, subject to the passing of the Placing Resolutions at the General Meeting."

[greendragon777] 03/10/2017 11:34

I thought you were snoozin' Paps! Haha

Seems to sliding ever so slightly but I guess it's to expected as the dilution is actually crystallized. When are the additional shares actually issued do you know?

I wonder is there any live streaming available for the upcoming presentations?

Anyway, back to playing the patient game.....it's gonna be a looooong winter! 😁

[papillon] 03/10/2017 11:19

AMYT chart. Make of it what you will. It shows the 50 day & 200 day SMA.


free stock charts from uk.advfn.com

[papillon] 02/10/2017 20:09

"Pap you are taking the old man stuff all Victor Meldrew. Patience old chap. Sea mail rather than Airo."

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

I'm afraid your post has completely baffled me, waterloo, especially "Sea mail rather than Airo"? What does it all mean?

Anyway back to sleep until we get some good news issued!

[greendragon777] 02/10/2017 17:44

Agreed Waterloo....all in it's own good time! 😁

[greendragon777] 02/10/2017 17:33

Haha.....he might need to get his radar fixed! :-)

I'm still of the opinion thought that the share price has in fact moved up relative to where it was given that the dilution equates to circa 25% and the share price only fell 10% to 12% or so. Company is in good shape right now as far as I'm concerned and the only thing we need is a little patience.

A good time for another snooze I think! haha

[waterloo01] 02/10/2017 17:30

Pap you are taking the old man stuff all Victor Meldrew. Patience old chap. Sea mail rather than Airo.

[papillon] 02/10/2017 17:00

radar
Posts: 2,607
Off Topic
Opinion: No Opinion
Price: 22.00
WhyToday 08:55Is all gone so very quiet and no updates.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Is radar being serious? His nickname is a misnomer, because the torrent of recent news issued by the company is obviously not appearing on his "radar" screen! LOL. Sometimes I despair of PI's.

We've had nothing, but updates in the past 4 weeks: the interim results RNS, the presentation in New York, the placing RNS & now yet another presentation on Thursday the 5th. Unfortunately this "newsflow" has done NOTHING for the sp! What we need is news that makes the share price take off and we might have to wait until next year for that news. Unfortunately we don't know what's going on behind the scenes; only the BoD and senior management are privy to that. We only get to know when something is finalised.

[greendragon777] 02/10/2017 13:08

I agree Paps, I have resigned myself to the fact that the share price won't move significantly until at least the middle of next year. That's fine by me though if takes a massive leap upwards at that stage! :-)

[papillon] 02/10/2017 12:58

It's NEWS that drives the share prices of AIM listed companies, greendragon, not presentations. I have a sneaking suspicion that, unless AMYT issue another licensing deal like that of Lojuxta in the meantime, we might have to wait until next year and the news on AP101 before investors "wake up to this company". Hope I'm proved wrong!

[greendragon777] 02/10/2017 12:52

As BWD mentioned here last week Paps, I think it takes a bit of time for these types of companies to catch the eye of the institutional investors hence all the presentations etc.

Hopefully it will advance a good bit this month under that heading. When the market finally wakes up to this company, it'll be like a gold rush! haha

[papillon] 02/10/2017 12:33

Yet another AMYT presentation on Thursday the 5th. I ask myself what's the point of all these presentations because they don't appear to generate any buying interest from investors. It smacks of desperation to me; a company desperate to attract interest in the company.

[papillon] 01/10/2017 12:34

Thanks, waterloo01

"AIM-listed Amryt Pharma is preparing to launch a treatment for epidermolysis bullosa, a rare genetic disorder which causes skin to tear at the slightest touch. Young sufferers are known as butterfly children. Amryt’s Oleogel, derived from birch tree bark, has been shown to help their wounds heal more quickly."

This comes from the following article:

[waterloo01] 01/10/2017 09:03

Small name check in Sunday Times business section re it's Birch bark based treatment for EB

[timbo003] 30/9/2017 12:43

Amryt will be at Proactiveinvestors on Thursday evening, you need to register to attend, but it's free! I've booked my place.

[papillon] 29/9/2017 10:55

140k volume so far today, but only 2 trades. 40k @ 2.13p (a buy?) and a 100k sell @ 2.00p. Definitely not paperboy trades! LOL.

[papillon] 27/9/2017 16:39

Spoke too soon. Delayed reporting of OK trade for 100k just announced. It was at 13:30:35 for 22.25p per share. I'm assuming it is a buy because the spread at that time was 22.00-22.25p and was raised immediately after that trade to 22.00-22.50p.